Direct Healthcare Professional Communication (DHPC) on Voxzogo® (vosoritide): change to administration syringe and needle leading to product administration in Units (U) instead of mL
2023.08.01
Active substance: vosoritide
BioMarin International Limited in agreement with the European Medicines Agency (EMA) and the Federal Institute for Drugs and Medical Devices (BfArM) would like to inform you that from August 2023, Voxzogo co-packs will contain new solvent needles and new administration syringes due to supply chain reasons. The new administration syringe has Units (U) graduation markings( typically used for insulin products and sometimes referred to as Insulin Units) instead of mL graduation markings.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN